FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC: Form 990, tax year 2018

View the entire original 990 at ProPublica ↗

Organization: FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC (EIN 52-1986675)
Tax period: 2018-01-01 to 2018-12-31
Filed: 2019-11-15
IRS object ID: 201923199349311947
Schema version: 2018v3.1
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule M
Schedule O

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2019-11-15T14:13:58-06:00	ReturnTs
Tax Period End	2018-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	560747981	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	DIXON HUGHES GOODMAN LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	901 EAST CARY STREET SUITE 1000	AddressLine1Txt
City	RICHMOND	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	23219	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2018-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	521986675	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	FOUNDATION FOR THE NATIONAL INSTITUTES	BusinessNameLine1Txt
Business Name Line2	OF HEALTH INC	BusinessNameLine2Txt

Field	Value	IRS element (for citing)
Business Name Control	FOUN	BusinessNameControlTxt
Phone	3014025311	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	11400 ROCKVILLE PIKE NO 600	AddressLine1Txt
City	NORTH BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20852	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	MARIA C FREIRE PHD	PersonNm
Person Title	PRESIDENT	PersonTitleTxt
Phone	3014025311	PhoneNum
Signature	2019-11-15	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	LAKRISHA J WATSON	PreparerPersonNm
PTIN	P01677333	PTIN
Phone	8042827636	PhoneNum
Preparation	2019-11-15	PreparationDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

Field	Value	IRS element (for citing)
I Pv4 Address	4.28.226.33	IPv4AddressTxt

Field	Value	IRS element (for citing)
IP	2019-11-15	IPDt
IP Tm	13:56:04	IPTm
IP Timezone	ES	IPTimezoneCd
Filing License Type	P	FilingLicenseTypeCd
At Submission Creation Device Id	DA39A3EE5E6B4B0D3255BFEF95601890AFD80709	AtSubmissionCreationDeviceId
At Submission Filing Device Id	3CD412B09983E39150554DEC6362464A9D6A3E5C	AtSubmissionFilingDeviceId

Field	Value	IRS element (for citing)
Tax	2018	TaxYr
Build TS	2020-03-31 21:24:44Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	MARIA C FREIRE PHD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	11400 ROCKVILLE PIKE NO 600	AddressLine1Txt
City	NORTH BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20852	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$153,516,193	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	HTTP://WWW.FNIH.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1996	FormationYr
Legal Domicile State	MD	LegalDomicileStateCd
Activity Or Mission	THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH (FNIH) CREATES AND LEADS ALLIANCES AND PUBLIC-PRIVATE PARTNERSHIPS THAT ADVANCE BREAKTHROUGH BIOMEDICAL DISCOVERIES AND IMPROVE THE QUALITY OF PEOPLE'S LIVES.	ActivityOrMissionDesc
Voting Members Governing Body	25	VotingMembersGoverningBodyCnt
Voting Members Independent	24	VotingMembersIndependentCnt
Total Employee	65	TotalEmployeeCnt
Total Volunteers	0	TotalVolunteersCnt
Total Gross UBI	$0	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$42,795	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$61,322,159	PYContributionsGrantsAmt
CY Contributions Grants	$60,444,618	CYContributionsGrantsAmt
PY Program Service Revenue	$111,660	PYProgramServiceRevenueAmt
CY Program Service Revenue	$64,723	CYProgramServiceRevenueAmt
PY Investment Income	$1,398,198	PYInvestmentIncomeAmt
CY Investment Income	$2,926,669	CYInvestmentIncomeAmt
PY Other Revenue	$46,023	PYOtherRevenueAmt
CY Other Revenue	$21,286	CYOtherRevenueAmt
PY Total Revenue	$62,878,040	PYTotalRevenueAmt
CY Total Revenue	$63,457,296	CYTotalRevenueAmt
PY Grants And Similar Paid	$34,963,149	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$19,403,180	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$7,128,157	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$8,639,303	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$0	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$78,000	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$221,918	CYTotalFundraisingExpenseAmt
PY Other Expenses	$14,572,507	PYOtherExpensesAmt
CY Other Expenses	$14,072,429	CYOtherExpensesAmt
PY Total Expenses	$56,663,813	PYTotalExpensesAmt
CY Total Expenses	$42,192,912	CYTotalExpensesAmt
PY Revenues Less Expenses	$6,214,227	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$21,264,384	CYRevenuesLessExpensesAmt
Total Assets BOY	$120,432,415	TotalAssetsBOYAmt
Total Assets EOY	$142,893,974	TotalAssetsEOYAmt
Total Liabilities BOY	$9,944,796	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$12,991,167	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$110,487,619	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$129,902,807	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	SEE SCHEDULE O, STATEMENT OF ORGANIZATION'S PRIMARY EXEMPT PURPOSE STATEMENTTHE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH WAS ESTABLISHED BY THE UNITED STATES CONGRESS TO SUPPORT THE NIH IN ITS MISSION TO IMPROVE HEALTH, BY FORMING AND FACILITATING PUBLIC-PRIVATE PARTNERSHIPS FOR BIOMEDICAL RESEARCH AND TRAINING. THE FOUNDATION BUILDS PARTNERSHIP FOR DISCOVERY AND INNOVATION TO IMPROVE HEALTH. THE BOARD HAS AN EXECUTIVE COMMITTEE WHICH CAN MAKE DECISIONS ON BEHALF OF THE BOARD (WITH SOME EXCEPTIONS) IN BETWEEN BOARD MEETINGS.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$34,161,888	ExpenseAmt
Grant	$18,522,487	GrantAmt
Revenue	$64,723	RevenueAmt
Desc	SEE SCHEDULE O, PROGRAM ONE, RESEARCH PARTNERSHIPSPROGRAM ONE - RESEARCH PARTNERSHIPS -INVESTIGATING NEW TREATMENTS FOR LUNG CANCER PATIENTSSHORTNESS OF BREATH. EXHAUSTION. LOSS OF APPETITE. THESE ARE JUST SOME OF THE SYMPTOMS EXPERIENCED BY PATIENTS WITH LUNG AND BRONCHIAL CANCER, WHICH REMAINS THE SECOND MOST COMMON CANCER DIAGNOSIS IN THE UNITED STATES ACCORDING TO THE NATIONAL CANCER INSTITUTE (NCI). ABOUT 85 PERCENT OF THOSE DIAGNOSED HAVE NON-SMALL CELL LUNG CANCER, A DISEASE IN WHICH CANCER CELLS FORM IN THE TISSUES OF THE LUNG.IN 2018, THE FNIH, NCI AND PARTNERS PREPARED FOR A MAJOR EXPANSION OF THE LUNG CANCER MASTER PROTOCOL (LUNG-MAP) CLINICAL TRIAL. THE TRIAL PREVIOUSLY TESTED TREATMENTS FOR PEOPLE WITH ADVANCED STAGE SQUAMOUS CELL LUNG CANCER. IT IS NOW OPEN TO PATIENTS WITH ALL TYPES OF ADVANCED STAGE NON-SMALL CELL LUNG CANCER. THIS DEVELOPMENT WILL ENABLE THOUSANDS OF NEW PATIENTS TO ENROLL IN LUNG-MAP, JOINING THE MORE THAN 1,800 PATIENTS, LIKE ANNIE BURKE, ALREADY PARTICIPATING AT 640 U.S. MEDICAL CENTERS AND COMMUNITY HOSPITALS ACROSS THE COUNTRY.LAUNCHED IN 2014, LUNG-MAP IS THE FIRST MAJOR NCI CANCER TRIAL TO TEST MULTIPLE CANCER TREATMENTS SIMULTANEOUSLY UNDER ONE "UMBRELLA" DESIGN. THIS PIONEERING RESEARCH MODEL IS MORE FLEXIBLE AND FASTER THAN TRADITIONAL CLINICAL TRIALS AS IT ENABLES RESEARCHERS TO SHARE ONE TRIAL STRUCTURE AND RECRUITMENT PROCESS. PATIENTS ARE TESTED ONCE FOR MORE THAN 200 CANCER-RELATED GENETIC ALTERATIONS BEFORE THEY ARE ASSIGNED TO INVESTIGATIONAL TREATMENT STUDIES BASED ON THEIR UNIQUE TUMOR PROFILE. PATIENTS WITHOUT A MATCHING GENETIC ALTERATION FOR A CORRESPONDING THERAPY WITHIN LUNG-MAP ARE PLACED ON AN IMMUNOTHERAPY REGIME."A GREAT THING ABOUT THE LUNG-MAP DESIGN IS THAT THE PATIENTS CAN MOVE FROM ONE STUDY TO THE NEXT TO THE NEXT," SAID JESSICA JORDAN, RESEARCH COORDINATOR, VA CONNECTICUT HEALTHCARE SYSTEMS. "EVERY SINGLE STUDY THESE DAYS REQUIRES TISSUE. WE ONLY HAVE TO SUBMIT ONE BLOCK OF TISSUE AND A PATIENT IS POTENTIALLY ABLE TO RECEIVE MORE THAN ONE LINE OF TREATMENT ON THE TRIAL IF THEIR GENERAL HEALTH ALLOWS. THAT'S THE MAJOR BENEFIT."THE TRIAL HAS ALREADY COMPLETED SEVEN OUT OF 10 LAUNCHED STUDIES, WITH TWO MORE SUB-STUDIES SCHEDULED TO OPEN IN 2019, OFFERING PATIENTS A PERSONALIZED APPROACH TO FINDING THE INVESTIGATIONAL DRUGS THAT WILL FIGHT THEIR CANCER. IMPROVE DIAGNOSIS OF KIDNEY INJURYIN 2018, THE FNIH BIOMARKERS CONSORTIUM ACHIEVED AN UNPRECEDENTED MILESTONE BY RECEIVING THE FIRST EVER QUALIFICATION OF A CLINICAL SAFETY BIOLOGICAL MARKER (BIOMARKER) AWARDED BY THE U.S. FOOD AND DRUG ADMINISTRATION (FDA). THE QUALIFICATION APPLIES TO A COMPOSITE MEASURE OF SIX URINE BIOMARKERS THAT RELIABLY CHANGE IN RESPONSE TO DRUG-INDUCED KIDNEY INJURY PRIOR TO IRREVERSIBLE DAMAGE AND EARLIER THAN TRADITIONAL BIOMARKERS. THIS SET OF BIOMARKERS CAN NOW BE USED TO AID IN THE DETECTION OF ACUTE KIDNEY INJURY IN HEALTHY VOLUNTEERS DURING EARLY PHASE CLINICAL TRIALS. IT WILL HELP IMPROVE THE DEVELOPMENT OF SAFE AND EFFECTIVE MEDICINES FOR PATIENTS WHERE CONCERN HAS BEEN RAISED THAT AN INVESTIGATIONAL DRUG MAY CAUSE KIDNEY INJURY.THIS MAJOR MILESTONE WAS MADE POSSIBLE BY THE RELENTLESS EFFORTS OF GOVERNMENT, NOT-FOR-PROFIT AND INDUSTRY PARTNERS SHARING INTELLECTUAL AND FINANCIAL RESOURCES TO FAST-TRACK THE DEVELOPMENT OF THESE CRITICAL BIOMARKERS. THE PATHWAY SET FORTH BY THE TEAM MAY HELP OTHERS SUBMITTING BIOMARKERS FOR QUALIFICATION BY THE FDA, EXPLAINED STEFAN SULTANA, M.D.,: "THE CUTTING-EDGE IS A LONELY PLACE TO BE BECAUSE NO ONE HAS BEEN DOWN THIS PATH BEFORE, SO WE'RE DEVELOPING NEW SCIENCE AND NEW WAYS OF DOING THINGS WITH THE REGULATORY AGENCIES. HOPEFULLY THE LESSONS WE LEARNED MAKE IT A LOT EASIER FOR OTHER GROUPS TO PURSUE QUALIFICATION OF SAFETY BIOMARKERS."TRACKING KNEE OSTEOARTHRITISMILLIONS OF PEOPLE WORLDWIDE WILL EXPERIENCE OSTEOARTHRITIS AS THEY AGE, AS IT IS THE MOST COMMON DISORDER OF THE JOINTS AND A MAJOR CAUSE OF DISABILITY IN OLDER ADULTS. DESPITE ITS PREVALENCE, THERE REMAINS A LACK OF TOOLS TO ACCURATELY EVALUATE PATIENTS, WHICH MAKES IT DIFFICULT TO DEVELOP NEW TREATMENTS.IN 2018, THE FNIH BIOMARKERS CONSORTIUM LAUNCHED A NEW PROJECT THAT WILL HELP PHYSICIANS AND PATIENTS, LIKE CINDY COPENHAVER, BETTER UNDERSTAND KNEE OSTEOARTHRITIS. RESEARCHERS WILL SEEK REGULATORY QUALIFICATION OF A NEW SET OF IMAGING (I.E., MRI) AND BIOCHEMICAL (I.E., URINE, SERUM) BIOMARKERS THAT PREDICT STRUCTURAL CHANGES IN THE JOINT CAUSED BY KNEE OSTEOARTHRITIS OVER TIME. THE FNIH IDENTIFIED THESE BIOMARKERS THROUGH A PREVIOUS PROJECT AND SHOWED THAT THEY MORE PRECISELY PREDICT AND MONITOR CHANGES IN THE KNEE COMPARED TO THE CURRENT STANDARD THAT USES X-RAY IMAGES. THE ACCEPTANCE OF THESE BIOMARKERS FOR THE DEVELOPMENT OF NEW DRUGS WILL PAVE THE WAY FOR IMPROVED TREATMENT OPTIONS FOR OSTEOARTHRITIS PATIENTS.SHAPING PERSONALIZED CANCER THERAPIESNEARLY EVERYONE HAS A FAMILY MEMBER OR FRIEND AFFECTED BY CANCER. FORTUNATELY, RECENT ADVANCES IN IMMUNOTHERAPIES HAVE SHOWN PROMISING RESPONSES IN CERTAIN CANCER TYPES. WHAT RESEARCHERS STILL NEED TO UNCOVER IS HOW AND WHEN TO BEST PAIR AN IMMUNOTHERAPY TO A SPECIFIC PATIENT.IN 2018, THE FNIH, NIH, FDA AND 12 PHARMACEUTICAL COMPANIES CONTINUED THEIR WORK TO BETTER UNDERSTAND HOW IMMUNOTHERAPIES ARE EFFECTIVE IN SOME PATIENTS AND TO ACCELERATE THE DEVELOPMENT OF NEW TREATMENTS THROUGH THE PARTNERSHIP FOR ACCELERATING CANCER THERAPIES (PACT). LEVERAGING THEIR COLLECTIVE EXPERTISE, CAPABILITIES AND RESOURCES, THE PARTNERS SET OUT TO IDENTIFY AND DEVELOP ROBUST, STANDARDIZED BIOMARKERS AND TESTS THAT WILL SUPPORT THE SELECTION AND CLINICAL TESTING OF IMMUNE-ONCOLOGY AND COMBINATION THERAPIES FOR PATIENTS. THESE BIOMARKERS AND TESTS WILL BE SHARED WITH THE BROADER RESEARCH COMMUNITY SO THAT THEY CAN BE USED EFFECTIVELY IN CLINICAL TRIALS CONDUCTED ANYWHERE IN THE CANCER FIELD."THE PACT TEAM HAS WORKED ACROSS BARRIERS TO BRING DIFFERENT PEOPLE TOGETHER TO DO SOMETHING THAT WOULD BE DIFFICULT TO DO ALONE," EXPLAINED JEFFREY ABRAMS, M.D., DIRECTOR, CLINICAL RESEARCH, DIVISION OF CANCER TREATMENT AND DIAGNOSIS, AND ASSOCIATE DIRECTOR OF THE CANCER THERAPY EVALUATION PROGRAM, NATIONAL CANCER INSTITUTE (NCI), RETIRED. "THE CHALLENGE OF OUR TIME WILL BE TO MAKE IMMUNOTHERAPIES WORK EVEN BETTER FOR INDIVIDUAL PATIENTS TO GENERATE THE RAPID PROGRESS THAT WE'D ALL LIKE TO SEE."EXPANDING THE ACCELERATING MEDICINES PARTNERSHIPTHE ACCELERATING MEDICINES PARTNERSHIP (AMP) HAS SERVED AS AN EFFECTIVE VEHICLE FOR PUBLIC-PRIVATE PARTNERSHIPS IN BIOMEDICAL RESEARCH SINCE 2014. AMP INITIALLY BROUGHT TOGETHER THE FNIH, NIH AND FDA WITH NOT-FOR-PROFIT ORGANIZATIONS AND INDUSTRY TO ACCELERATE EARLY-STAGE DRUG DEVELOPMENT IN ALZHEIMER'S DISEASE, TYPE 2 DIABETES AND THE AUTOIMMUNE DISORDERS RHEUMATOID ARTHRITIS (RA) AND SYSTEMIC LUPUS ERYTHEMATOSUS. BY ENABLING JOINT PLANNING OF RESEARCH IN THE HIGHEST AREAS OF NEED AND SHARING RESOURCES, EXPERTISE AND DATA, AMP HAS MADE SIGNIFICANT PROGRESS IN UNDERSTANDING DISEASE PATHWAYS AT THE MOLECULAR LEVEL AND IN IDENTIFYING NEW TARGETS FOR TREATMENTS. ALL OF THE DATA GENERATED FROM AMP ARE MADE BROADLY AVAILABLE TO THE RESEARCH COMMUNITY THROUGH ONLINE KNOWLEDGE PORTALS FOR USE IN DRUG DISCOVERY AND DEVELOPMENT.IN 2018, THE AMP TEAM EXPANDED WORK IN TWO KEY AREAS:1. LAUNCH OF AMP PARKINSON'S DISEASE (AMP PD): THE NUMBER OF PEOPLE LIVING WITH PARKINSON'S DISEASE IS EXPECTED TO NEARLY DOUBLE BY 2040, ACCORDING TO THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE, AND THERE ARE STILL NO DISEASE-MODIFYING DRUGS (NINDS) APPROVED FOR TREATMENT. THROUGH THE NEW AMP PD PROGRAM, RESEARCHERS WILL TRANSFORM THE CURRENT MODEL FOR DEVELOPING DIAGNOSTICS AND TREATMENTS FOR PATIENTS BY IDENTIFYING AND VALIDATING BIOMARKERS THAT TRACK DISEASE PROGRESSION AND SERVE AS NEW DRUG TARGETS.2. EXTENSION OF AMP RA/LUPUS TO A 6TH YEAR: THIS PROGRAM EXTENSION WILL ENABLE RESEARCHERS TO DEPLOY EMERGING TECHNOLOGIES THAT CAN FURTHER ANALYZE TISSUE, BLOOD AND URINE SAMPLES FROM PATIENTS LIVING WITH RA OR LUPUS. THE PROGRAM WILL CREATE A MORE DETAILED UNDERSTANDING OF THE MOLECULAR NATURE OF THESE DISEASES. BY EXAMINING SAMPLES AT THE SINGLE-CELL LEVEL RESEARCHERS ARE IDENTIFYING THE GENES, PROTEINS AND CHEMICAL PATHWAYS THAT PLAY IMPORTANT ROLES IN THESE DISEASES AND UNCOVERING NEW TARGETS FOR DRUG DEVELOPMENT.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$1,074,653	ExpenseAmt
Grant	$792,028	GrantAmt
Desc	SEE SCHEDULE O, PROGRAM TWO, EDUCATION, TRAINING AND PATIENT SUPPORT PROGRAMSPROGRAM TWO - EDUCATION, TRAINING AND PATIENT SUPPORT PROGRAMS - THE CRITICAL ROLE OF CLINICIAN-SCIENTISTS CLINICIAN-SCIENTISTS FULFILL AN ESSENTIAL AND UNIQUE ROLE IN MEDICINE. THEY CONDUCT RESEARCH THAT APPLIES BASIC SCIENTIFIC KNOWLEDGE TO CLINICAL PROBLEMS ULTIMATELY HARNESSING DISCOVERY FROM THE LABORATORY AND APPLYING IT DIRECTLY TO PATIENT CARE. YET, THE NUMBER OF THOSE EMBARKING ON CAREERS IN THIS VITALLY IMPORTANT FIELD IS DECLINING.IN 2018, THE FNIH LAUNCHED THE TRAILBLAZER PRIZE FOR CLINICIAN-SCIENTISTS, MADE POSSIBLE WITH GENEROUS SUPPORT FROM JOHN I. GALLIN, M.D., AND ELAINE K. GALLIN, PH.D., TO RECOGNIZE THE OUTSTANDING CONTRIBUTIONS OF EARLY CAREER CLINICIAN-SCIENTISTS WHOSE WORK HAS THE POTENTIAL TO OR HAS LED TO INNOVATIONS IN PATIENT CARE. THE TRAILBLAZER PRIZE IS AN OPPORTUNITY TO SHINE A LIGHT ON THE ESSENTIAL MEDICAL CONTRIBUTIONS OF CLINICIAN-SCIENTISTS AND INSPIRE THE NEXT-GENERATION TO JOIN THE FIELD.AFTER RECEIVING MORE THAN 100 NOMINATIONS, THE JURY SELECTED THREE FINALISTS: DANIEL BAUER, M.D., PH.D., HARVARD MEDICAL SCHOOL, JAEHYUK CHOI, M.D., PH.D., FEINBERG SCHOOL OF MEDICINE, NORTHWESTERN UNIVERSITY AND MICHAEL FOX, M.D., PH.D., BETH ISRAEL DEACONESS MEDICAL CENTER, HARVARD MEDICAL SCHOOL. IN OCTOBER, THE FINALISTS JOINED THE FNIH FOR AN EVENT ON CAPITOL HILL TO EXPLAIN THEIR RESEARCH AND OFFER INSIGHTS ABOUT THEIR PROFESSION TO CONGRESSIONAL STAFFERS. THE FNIH ANNUAL FALL BOARD DINNER FOLLOWED THAT EVENING, WHERE THE FNIH ANNOUNCED DR. FOX AS THE PRIZE WINNER FOR PIONEERING INNOVATIVE TECHNIQUES TO MAP HUMAN BRAIN CONNECTIVITY THAT CAN BE TRANSLATED INTO NEW TREATMENTS FOR NEUROLOGICAL DISEASES."THE PURPOSE OF OUR LAB IS TO TRANSLATE HUMAN BRAIN CONNECTIONS INTO NEW PATIENT CARE," EXPLAINED DR. FOX. "AS WE LEARN THAT DIFFERENT SYMPTOMS MAP TO DIFFERENT BRAIN CIRCUITS, WE TAILOR OUR TREATMENTS TO THOSE SYMPTOMS, RATHER THAN TREATING ALL PATIENTS THE SAME WAY. ONE OF MY PATIENTS HAD PARKINSON'S DISEASE AND A MEDICATION REFRACTORY TREMOR. THROUGH DEEP BRAIN STIMULATION THERAPY, HE EXPERIENCED NOT HAVING THE TREMOR FOR THE FIRST TIME IN 12 YEARS."DR. FOX'S WORK EXEMPLIFIES HOW CLINICIAN-SCIENTISTS DRIVE INNOVATIONS FOR PATIENT CARE. THROUGH THE TRAILBLAZER PRIZE, THE FNIH WILL CONTINUE TO SHOWCASE THEIR SIGNIFICANT CONTRIBUTIONS THAT CAN BE LIFE-CHANGING FOR PATIENTS NOW AND IN THE FUTURE.A NEW TOOL WITH POTENTIAL TO ELIMINATE MALARIAFOLLOWING YEARS OF SUCCESS IN REDUCING MALARIA ACROSS THE GLOBE, PROGRESS HAS STALLED. ACCORDING TO THE WORLD HEALTH ORGANIZATION, THERE WERE AN ESTIMATED 219 MILLION CASES OF MALARIA IN 2017, AN INCREASE FROM 217 MILLION IN 2016. REDUCTIONS IN MORTALITY RATES HAVE SIMILARLY PLATEAUED AND SCIENTISTS, COUNTRIES AND COMMUNITIES FIND THEMSELVES AT A CRITICAL JUNCTURE."THERE HAS BEEN LITTLE INNOVATION IN MALARIA CONTROL AND SO FOR THE FIRST TIME WITH THE COMING OF TECHNOLOGY LIKE GENE DRIVE, PARTICULARLY AFTER THE DISCOVERY OF THE GENE EDITING TECHNIQUE CRISPR, MANY OF US STARTED TO BELIEVE THAT WE HAVE A TOOL NOW THAT COULD POTENTIALLY BE REVOLUTIONARY. NONETHELESS, MORE RESEARCH IS NEEDED TO ASSESS BENEFITS AND RISKS. AND THAT'S WHAT WE ARE ASKING OUR SCIENTISTS TO DO," EXPLAINED FREDROS OKUMU, PH.D.GENE DRIVE IS A MECHANISM THAT PROMOTES THE PREFERENTIAL INHERITANCE OF A GENETIC TRAIT TO INCREASE ITS PREVALENCE IN A POPULATION. RECENT ADVANCES IN GENE EDITING ALLOW THIS NATURAL MECHANISM TO BE MIMICKED IN THE LABORATORY. MANY APPLICATIONS OF THIS EMERGING TECHNOLOGY ARE BEING CONSIDERED, INCLUDING ITS USE ON MOSQUITOES TO REDUCE THE TRANSMISSION OF MOSQUITO-BORNE DISEASES, SUCH AS MALARIA. AS THE TECHNOLOGY IS STILL IN ITS EARLY STAGES, IT REQUIRES CAREFUL CONSIDERATION AND ASSESSMENT BEFORE GENE DRIVE PRODUCTS CAN BE FIELD-TESTED AND DEPLOYED.THE FNIH IS WORKING WITH PARTNERS LIKE DR. OKUMU TO FACILITATE IMPORTANT DISCUSSIONS ON GENE DRIVE TECHNOLOGY AMONG VARIOUS STAKEHOLDERS TO DEVELOP AND SHARE BEST PRACTICES, TECHNICAL ADVICE AND TRAINING TO ADVANCE RESPONSIBLE RESEARCH. IN 2018, DR. OKUMO WAS PART OF AN FNIH-LED WORKING GROUP THAT PRESENTED THEIR PAPER AT THE AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE (ASTMH) ANNUAL MEETING, WHICH OUTLINES RECOMMENDATIONS FOR THE SAFE AND ETHICAL TESTING OF GENE DRIVE TECHNOLOGY ON MOSQUITOES TO REDUCE THE BURDEN OF MALARIA TRANSMISSION IN AFRICA. PREVIOUSLY PUBLISHED IN ASTMH'S SCIENTIFIC JOURNAL, THE PAPER PROPOSES A PATHWAY FOR THE RESPONSIBLE DEVELOPMENT AND TESTING OF GENE DRIVE PRODUCTS."OUR INTEREST NOW IS TO ENCOURAGE SCIENTISTS TO INVESTIGATE THE POTENTIAL OF THE TECHNOLOGY," SAID DR. OKUMU. "IF WE DON'T DO SCIENTIFIC RESEARCH ON THIS TECHNOLOGY THEN WE WON'T BE ABLE TO UNDERSTAND IT. GIVEN THE COMPLEXITY ASSOCIATED WITH THIS TOOL, IT IS ONLY RIGHT TO BRING EVERYONE TOGETHER TO TRY TO MAKE SURE PEOPLE ARE SPEAKING THE SAME LANGUAGE. MAYBE FOR THE FIRST TIME, IF WE DO THINGS RIGHT, WE COULD HAVE A TOOL THAT DRAMATICALLY SHIFTS THE NEEDLE TOWARDS THE DREAM OF MALARIA ELIMINATION WHICH HAS BEEN ELUSIVE FOR A LONG TIME."	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$852,380	ExpenseAmt
Grant	$10,000	GrantAmt
Desc	SEE SCHEDULE O, PROGRAM THREE, PATIENT SUPPORT PROGRAM/CAPITAL PROJECTPROGRAM THREE - PATIENT SUPPORT PROGRAM/CAPITAL PROJECT -RENOVATING A SAFE HAVEN FOR NIH PATIENTS AND FAMILIESPARTICIPATING IN MEDICAL RESEARCH IS OFTEN THE LAST CHANCE FOR PATIENTS TO FIND A NEW, POTENTIALLY LIFE-SAVING THERAPY TO FIGHT THEIR DISEASE. PATIENTS AND THEIR FAMILIES TRAVEL FAR FROM HOME TO ACCESS CLINICAL TRIALS, LEAVING WORK BEHIND TO LIVE IN HOTELS FOR MONTHS A REALITY THAT CAN BE DRAINING, STRESSFUL AND COSTLY.DURING THIS DIFFICULT TIME, THE EDMOND J. SAFRA FAMILY LODGE PROVIDES A HAVEN FOR THESE BRAVE FAMILIES ON THE NIH CAMPUS. ADULT PATIENTS PARTICIPATING IN MEDICAL RESEARCH AT THE NIH CLINICAL CENTER AND THEIR FAMILIES CAN STAY AT THE FAMILY LODGE AT NO COST TO THEM. IN 2018, THE FNIH AND NIH, WITH SUPPORT FROM FNIH BOARD MEMBER LILY SAFRA AND THE EDMOND J. SAFRA FOUNDATION, PARTNERED TO RENOVATE THE FAMILY LODGE, WHICH WAS SHOWING SIGNS OF WEAR AFTER 12 YEARS OF CONTINUOUS USE. THE TEAM DELICATELY BALANCED MINIMIZING DISRUPTION TO THE DAILY OPERATIONS WHILE MAKING ENHANCEMENTS, SUCH AS NEW LIGHTING, PAINT, CARPET AND DRAPERY, FOR THE 34 GUEST ROOMS AND COMMON AREAS."THEY DID A GREAT JOB WITH RENOVATING THE FAMILY LODGE," SAID DAVID HAAS. "IT HAS BEEN AN IMPORTANT PART OF MY FAMILY'S JOURNEY AT THE NIH. FROM TALKING WITH OTHER GUESTS, I HEAR DIFFERENT STORIES ABOUT HOW NIH'S CUTTING-EDGE RESEARCH IS HELPING PEOPLE FROM ALL OVER THE WORLD. IT'S VITALLY IMPORTANT THAT THEY CONTINUE THAT WORK, AND THAT FAMILIES HAVE A PLACE TO STAY NEARBY."	Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

Field	Value	IRS element (for citing)
Expense	$486,093	ExpenseAmt
Grant	$78,665	GrantAmt
Desc	PROGRAM FOUR - MEMORIALS, AWARDS, AND EVENTS	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$486,093	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$78,665	TotalOtherProgSrvcGrantAmt
Total Program Service Expenses	$36,575,014	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	Yes (1)	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	Yes (1)	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	Yes (1)	CreditCounselingInd
Temp Or Permanent Endowments	Yes (1)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	0	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (1)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (1)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	0	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	0	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	0	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (1)	ProfessionalFundraisingInd
Fundraising Activities	Yes (1)	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	Yes (1)	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	0	TaxExemptBondsInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	0	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	Yes (1)	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	0	DisregardedEntityInd
Related Entity	0	RelatedEntityInd
Related Organization Ctrl Ent	0	RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	26	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (1)	BackupWthldComplianceInd
Employee	65	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (1)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (1)	Form990TFiledInd
Foreign Financial Account	0	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (1)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (1)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt	0	SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc	0	SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	25	GoverningBodyVotingMembersCnt
Independent Voting Member	24	IndependentVotingMemberCnt
Family Or Business Rln	Yes (1)	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	0	MembersOrStockholdersInd
Election Of Board Members	0	ElectionOfBoardMembersInd
Decisions Subject To Approva	0	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	0	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CO	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	GA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	HI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ND	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NV	StatesWhereCopyOfReturnIsFldCd
Own Website	Yes (X)	OwnWebsiteInd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	DONALD M HILL	PersonNm
Phone	3014356246	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	11400 ROCKVILLE PIKE SUITE 600	AddressLine1Txt
City	NORTH BETHESDA	CityNm
State Abbreviation	MD	StateAbbreviationCd
ZIP	20852	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (37 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd
DR STEVEN M PAUL
CHAIRMAN	1.50	Yes (X)	Yes (X)	$0	$0	$0
DR SOLOMON H SNYDER
VICE-CHAIRMAN	0.50	Yes (X)	Yes (X)	$0	$0	$0
MR STEVEN C MAYER
TREASURER	2.00	Yes (X)	Yes (X)	$0	$0	$0
MRS WILLIAM MCCORMICK BLAIR JR
SECRETARY	1.00	Yes (X)	Yes (X)	$0	$0	$0
DR MARIA C FREIRE
PRESIDENT AND EXECUTIVE DIRECTOR	40.00	Yes (X)	Yes (X)	$472,786	$0	$27,500
DR KATHY BLOOMGARDEN
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
MRS WILLIAM N CAFRITZ
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR MARIJN DEKKERS
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
MR JAMES H DONOVAN
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR PAUL L HERRLING
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR THOMAS R INSEL
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR JUDY LANSING KOVLER
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR RONALD L KRALL
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR FREDA C LEWIS-HALL
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR EDISON T LIU
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
MR JOEL S MARCUS
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR PAUL M MONTRONE
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DAME JILLIAN SACKLER
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
MRS LILY SAFRA
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR CHARLES A SANDERS
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
MR FRED SEIGEL
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR ELLEN V SIGAL
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
MR RUSSELL W STEENBERG
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR PAUL STOFFELS
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
DR SAMUEL O THIER
BOARD OF DIRECTORS MEMBER	0.50	Yes (X)		$0	$0	$0
MS NINA SOLARZ
DIRECTOR THROUGH 12/21/18	0.50	Yes (X)		$0	$0	$0
MR DAVID WHOLLEY
SENIOR VP OF RESEARCH PARTNERSHIPS	40.00			$335,826	$0	$43,220	Yes (X)
DR STEPHANIE JAMES
SENIOR VP OF SCIENCE	40.00			$329,574	$0	$27,500	Yes (X)
MR DONALD HILL
CHIEF FINANCIAL OFFICER	40.00			$229,912	$0	$38,899	Yes (X)
MR KEVIN A KLOCK
VP OF OPERATIONS & GENERAL COUNSEL	40.00			$209,068	$0	$37,699	Yes (X)
MR ROBERT BALTHASER
VICE PRESIDENT OF ADVANCEMENT	40.00			$156,672	$0	$21,666	Yes (X)
MS JULIA WOLF-RODDA
SENIOR VP OF DEVELOPMENT	40.00			$216,062	$0	$36,799	Yes (X)
DR JOSEPH MENETSKI
ASSOCIATE VP OF RESEARCH PARTNERSHIPS	40.00			$215,262	$0	$34,519		Yes (X)
DR DAVID O'BROCHTA
SCIENTIFIC PROGRAM MANAGER	40.00			$179,788	$0	$32,047		Yes (X)
DR KAREN TOUNTAS
SCIENTIFIC PROGRAM MANAGER	40.00			$178,232	$0	$33,327		Yes (X)
DR STACEY ADAM
DIRECTOR OF CANCER	40.00			$165,609	$0	$22,576		Yes (X)
DR ROSA CANET AVILES
DIRECTOR OF NEUROSCIENCE	40.00			$163,632	$0	$32,170		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$2,852,423	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$387,922	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	23	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	0	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
SWOG CTI
24 FRANK LLOYD WRIGHT DRIVE PO BOX	ANN ARBOR	MI	48105	CONDUCTS CLINICAL TRIAL FOR LUNGMAP	$7,054,078
THE BROAD INSTITUTE INC
415 MAIN STREET	CAMBRIDGE	MA	02142	PROFESSIONAL SERVICES FOR THE AMP T2DIAB	$601,496
THE BOSTON CONSULTING GROUP INC
PO BOX 75200	CHICAGO	IL	60675	PROFESSIONAL SERVICES FOR BUSINESS PLAN	$505,000
SUSAN A VALLON LTD
4237 LENORE LANE NW	WASHINGTON	DC	20008	DESIGNING SERVICES FOR SAFRA LODGE	$431,200
AVID RADIOPHARMACEUTICALS INC
3711 MARKET STREET 7TH FLOOR	PHILADELPHIA	PA	19104	CONDUCTS CLINICAL TRIAL FOR AMP AD	$372,500

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	20	CntrctRcvdGreaterThan100KCnt
Fundraising	$60,606	FundraisingAmt
Government Grants	$2,000,000	GovernmentGrantsAmt
All Other Contributions	$58,384,012	AllOtherContributionsAmt
Noncash Contributions	$116,790	NoncashContributionsAmt
Total Contributions	$60,444,618	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

Field	Value	IRS element (for citing)
Desc	ADMINISTRATIVE FEES	Desc
Business	561000	BusinessCd
Total Revenue Column	$64,723	TotalRevenueColumnAmt
Related Or Exempt Func Income	$64,723	RelatedOrExemptFuncIncomeAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$64,723	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$2,057,158	TotalRevenueColumnAmt
Exclusion	$2,057,158	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$90,642,144	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$89,772,633	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$869,511	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$869,511	TotalRevenueColumnAmt
Exclusion	$869,511	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$307,550	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$60,606	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$286,264	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$21,286	TotalRevenueColumnAmt
Exclusion	$21,286	ExclusionAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$63,457,296	TotalRevenueColumnAmt
Related Or Exempt Func Income	$64,723	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$2,947,955	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$15,579,023	TotalAmt
Program Services	$15,579,023	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$25,597	TotalAmt
Program Services	$25,597	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$3,798,560	TotalAmt
Program Services	$3,798,560	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$2,183,183	TotalAmt
Program Services	$828,884	ProgramServicesAmt
Management And General	$1,304,205	ManagementAndGeneralAmt
Fundraising	$50,094	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$4,672,402	TotalAmt
Program Services	$2,854,419	ProgramServicesAmt
Management And General	$1,805,853	ManagementAndGeneralAmt
Fundraising	$12,130	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$497,210	TotalAmt
Program Services	$263,157	ProgramServicesAmt
Management And General	$222,677	ManagementAndGeneralAmt
Fundraising	$11,376	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$837,584	TotalAmt
Program Services	$482,972	ProgramServicesAmt
Management And General	$336,500	ManagementAndGeneralAmt
Fundraising	$18,112	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$448,924	TotalAmt
Program Services	$196,636	ProgramServicesAmt
Management And General	$252,288	ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$168,750	TotalAmt
Program Services	$132,198	ProgramServicesAmt
Management And General	$36,552	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$56,500	TotalAmt
Management And General	$56,500	ManagementAndGeneralAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$78,000	TotalAmt
Fundraising	$78,000	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$159,775	TotalAmt
Management And General	$159,775	ManagementAndGeneralAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$7,490	TotalAmt
Program Services	$1,438	ProgramServicesAmt
Management And General	$6,052	ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$21,425	TotalAmt
Program Services	$2,852	ProgramServicesAmt
Management And General	$18,497	ManagementAndGeneralAmt
Fundraising	$76	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$115,225	TotalAmt
Program Services	$52,803	ProgramServicesAmt
Management And General	$49,196	ManagementAndGeneralAmt
Fundraising	$13,226	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$538,714	TotalAmt
Program Services	$141,058	ProgramServicesAmt
Management And General	$397,656	ManagementAndGeneralAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$1,567,655	TotalAmt
Program Services	$1,491,938	ProgramServicesAmt
Management And General	$68,194	ManagementAndGeneralAmt
Fundraising	$7,523	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$173,807	TotalAmt
Management And General	$173,807	ManagementAndGeneralAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$174,493	TotalAmt
Program Services	$104,525	ProgramServicesAmt
Management And General	$69,968	ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
PROGRAM CONTRACTS	$11,748,431	$11,748,431
CONSULTANTS	$2,023,825	$1,783,975	$233,850	$6,000
HONORARIA	$111,150	$111,150
POSTAGE AND DELIVERY	$109,230	$100,598	$3,805	$4,827

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	-$2,904,041	TotalAmt
Program Services	-$3,125,200	ProgramServicesAmt
Management And General	$200,605	ManagementAndGeneralAmt
Fundraising	$20,554	FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$42,192,912	TotalAmt
Program Services	$36,575,014	ProgramServicesAmt
Management And General	$5,395,980	ManagementAndGeneralAmt
Fundraising	$221,918	FundraisingAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$25,197,544	BOYAmt
EOY	$23,800,394	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$23,480,012	BOYAmt
EOY	$17,270,547	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$154,153	BOYAmt
EOY	$229,753	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$2,428,720	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$875,296	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$1,653,277	BOYAmt
EOY	$1,553,424	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$69,726,056	BOYAmt
EOY	$99,554,021	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$221,373	BOYAmt
EOY	$485,835	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$120,432,415	BOYAmt
EOY	$142,893,974	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$3,704,459	BOYAmt
EOY	$3,884,772	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$3,382,073	BOYAmt
EOY	$6,070,167	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$1,240,626	BOYAmt
EOY	$1,235,000	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$1,617,638	BOYAmt
EOY	$1,801,228	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$9,944,796	BOYAmt
EOY	$12,991,167	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$15,970,742	BOYAmt
EOY	$18,067,390	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$91,433,211	BOYAmt
EOY	$108,642,245	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$3,083,666	BOYAmt
EOY	$3,193,172	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$110,487,619	BOYAmt
EOY	$129,902,807	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$120,432,415	BOYAmt
EOY	$142,893,974	EOYAmt

Field	Value	IRS element (for citing)
Reconcilation Revenue Expnss	$21,264,384	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$1,849,196	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	$0	OtherChangesInNetAssetsAmt
Info In Schedule O Part XII	Yes (X)	InfoInScheduleOPartXIIInd
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Separate Basis Fincl Stmt	Yes (X)	SeparateBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	0	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$73,905,546	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$33,961,607	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$82,860,385	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$61,322,159	CurrentTaxYearMinus1YearAmt
Current Tax Year	$60,444,618	CurrentTaxYearAmt
Total	$312,494,315	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$73,905,546	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$33,961,607	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$82,860,385	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$61,322,159	CurrentTaxYearMinus1YearAmt
Current Tax Year	$60,444,618	CurrentTaxYearAmt
Total	$312,494,315	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$136,924,351	SubstantialContributorsTotAmt
Public Support Total170	$175,569,964	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$214,303	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$367,897	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$574,125	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$1,066,052	CurrentTaxYearMinus1YearAmt
Current Tax Year	$2,057,158	CurrentTaxYearAmt
Total	$4,279,535	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$316,773,850	TotalSupportAmt
Gross Receipts Rltd Activities	$690,452	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.55420	PublicSupportCY170Pct
Public Support PY170	0.53930	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Volunteers	0	VolunteersInd
Paid Staff Or Management	Yes (1)	PaidStaffOrManagementInd
Media Advertisements	0	MediaAdvertisementsInd
Mailings Members	0	MailingsMembersInd
Publications Or Broadcast	0	PublicationsOrBroadcastInd
Grants Other Organizations	0	GrantsOtherOrganizationsInd
Direct Contact Legislators	Yes (1)	DirectContactLegislatorsInd
Rallies Demonstrations	0	RalliesDemonstrationsInd
Other Activities	0	OtherActivitiesInd
Total Lobbying Expenditures	$0	TotalLobbyingExpendituresAmt
Not Described Section501c3	0	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART II-B, LINE 1:	FormAndLineReferenceDesc
Explanation	FNIH CONSULTED ITS COMMITTEES OF JURISDICTION ON PUBLIC HEALTH LEGISLATION	ExplanationTxt

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Donor Advised Funds Held	2	DonorAdvisedFundsHeldCnt
Donor Advised Funds Contri	$2,500	DonorAdvisedFundsContriAmt
Donor Advised Funds Grants	$3,100	DonorAdvisedFundsGrantsAmt
Donor Advised Funds Vl EOY	$3,197,869	DonorAdvisedFundsVlEOYAmt
Disclosed Org Leg Ctrl	Yes (1)	DisclosedOrgLegCtrlInd
Disclosed For Charitable Prps	Yes (1)	DisclosedForCharitablePrpsInd
Agent Trustee Etc	0	AgentTrusteeEtcInd
Incl Escrow Custodial Acct Liab	Yes (1)	InclEscrowCustodialAcctLiabInd
Explanation Provided	Yes (X)	ExplanationProvidedInd

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$11,920,726	BeginningYearBalanceAmt
Contributions	$1,032,217	ContributionsAmt
Investment Earnings Or Losses	-$267,231	InvestmentEarningsOrLossesAmt
Other Expenditures	$103,397	OtherExpendituresAmt
Administrative Expenses	$67,504	AdministrativeExpensesAmt
End Year Balance	$12,514,811	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$9,704,030	BeginningYearBalanceAmt
Contributions	$1,721,204	ContributionsAmt
Investment Earnings Or Losses	$552,828	InvestmentEarningsOrLossesAmt
Administrative Expenses	$57,336	AdministrativeExpensesAmt
End Year Balance	$11,920,726	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$9,501,571	BeginningYearBalanceAmt
Contributions	$11,412	ContributionsAmt
Investment Earnings Or Losses	$243,278	InvestmentEarningsOrLossesAmt
Administrative Expenses	$52,231	AdministrativeExpensesAmt
End Year Balance	$9,704,030	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$9,616,660	BeginningYearBalanceAmt
Contributions	$10,356	ContributionsAmt
Investment Earnings Or Losses	-$100,829	InvestmentEarningsOrLossesAmt
Administrative Expenses	$24,616	AdministrativeExpensesAmt
End Year Balance	$9,501,571	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$3,381,374	BeginningYearBalanceAmt
Contributions	$6,271,975	ContributionsAmt
Investment Earnings Or Losses	$11,641	InvestmentEarningsOrLossesAmt
Administrative Expenses	$48,330	AdministrativeExpensesAmt
End Year Balance	$9,616,660	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Board Designated Balance EOY	0.71010	BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY	0.28990	PrmnntEndowmentBalanceEOYPct
Endowments Held Unrelated Org	0	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	0	EndowmentsHeldRelatedOrgInd

Leasehold Improvements LeaseholdImprovementsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$1,387,425	OtherCostOrOtherBasisAmt
Depreciation	$107,911	DepreciationAmt
Book Value	$1,279,514	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$1,041,295	OtherCostOrOtherBasisAmt
Depreciation	$767,385	DepreciationAmt
Book Value	$273,910	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$1,553,424	TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (3 entries)

DescDesc	AmtAmt
CHARITABLE GIFT ANNUITY	$137,937
DEFERRED LEASE INCENTIVE	$1,279,514
DEFERRED RENT LIABILITY	$383,777

Field	Value	IRS element (for citing)
Total Liability	$1,801,228	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$62,045,497	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$1,849,196	NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts	$310,908	DonatedServicesAndUseFcltsAmt
Revenue Not Reported	-$1,538,288	RevenueNotReportedAmt
Revenue Subtotal	$63,583,785	RevenueSubtotalAmt
Investment Expenses Not Incld	$159,775	InvestmentExpensesNotIncldAmt
Other Revenues Not Included	-$286,264	OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt	-$126,489	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$63,457,296	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$42,630,309	TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts	$310,908	DonatedServicesUseFcltsAmt
Other Expenses Included	$286,264	OtherExpensesIncludedAmt
Expenses Not Reported	$597,172	ExpensesNotReportedAmt
Expenses Subtotal	$42,033,137	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$159,775	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$159,775	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$42,192,912	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART IV, LINE 2B:	AS OF 12/31/2018, THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC HELD $1,235,000 IN AGENCY FUNDS FOR FUTURE DISTRIBUTIONS TO THE NATIONAL INSTITUTES OF HEALTH (NIH). THESE FUNDS ARE DESIGNATED BY THE FUNDER(S) FOR SPECIFIC PROJECTS AT THE NIH, AND WILL BE DISBURSED AS NEEDED.
PART V, LINE 4:	THE FOUNDATION HAS ONE ENDOWMENT THAT IS FUNDED BY MULTIPLE DONORS TO SEED NEW DISCOVERIES AND/OR BE AVAILABLE TO RESPOND TO EPIDEMICS AND FOUNDATION'S UNANTICIPATED NEEDS. THE FOUNDATION'S OTHER ENDOWMENTS CONSIST OF INDIVIDUAL DONOR-RESTRICTED ENDOWMENT FUNDS ESTABLISHED FOR A VARIETY OF PURPOSE. (E.G. VARIETY OF RESEARCH AND EDUCATIONAL INITIATIVES AT THE FOUNDATION FOR THE NIH, INC). NET ASSETS ASSOCIATED WITH ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OR ABSENCE OR DONOR-IMPOSED RESTRICTIONS.
PART X, LINE 2:	THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE; ACCORDINGLY, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT REFLECT A PROVISION OR LIABILITY FOR FEDERAL AND STATE INCOME TAXES. THE FOUNDATION HAS DETERMINED THAT IT DOES NOT HAVE ANY MATERIAL UNRECOGNIZED TAX BENEFITS OR OBLIGATIONS AS OF DECEMBER 31, 2018 AND 2017.
PART XI, LINE 4B - OTHER ADJUSTMENTS:	FUNDRAISING DIRECT EXPENSE -286,264.
PART XII, LINE 2D - OTHER ADJUSTMENTS:	FUNDRAISING DIRECT EXPENSE 286,264.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)

RegionRegionTxt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	GRANTMAKING	$2,269,532
SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL,	GRANTMAKING	$263,376
SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO,	GRANTMAKING	$1,265,652

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	0	SubtotalEmployeesCnt
Continuation Total Office	0	ContinuationTotalOfficeCnt
Continuation Total Employee	0	ContinuationTotalEmployeeCnt
Total Office	0	TotalOfficeCnt
Total Employee	0	TotalEmployeeCnt
Subtotal Spent	$3,798,560	SubtotalSpentAmt
Continuation Spent	$0	ContinuationSpentAmt
Total Spent	$3,798,560	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (13 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	RESEARCH	$799,316	WIRE TRANSFER
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	RESEARCH	$176,803	WIRE TRANSFER
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,	RESEARCH	$74,493	WIRE TRANSFER
SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO,	RESEARCH	$257,131	WIRE TRANSFER
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,	RESEARCH	$123,050	WIRE TRANSFER
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	RESEARCH	$192,556	WIRE TRANSFER
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	RESEARCH	$85,340	WIRE TRANSFER
SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO,	RESEARCH	$807,224	WIRE TRANSFER
SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO,	RESEARCH	$201,297	WIRE TRANSFER
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	RESEARCH	$670,149	WIRE TRANSFER
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,	RESEARCH	$45,833	WIRE TRANSFER
EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA,	RESEARCH	$20,000	WIRE TRANSFER
EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM	RESEARCH	$345,368	WIRE TRANSFER

Field	Value	IRS element (for citing)
Total501c3 Org	3	Total501c3OrgCnt
Total Other Org	10	TotalOtherOrgCnt
Transfer To Foreign Corp	0	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	0	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	0	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	PROGRAM AND GRANTS MANAGEMENT STAFF INVEST CONSIDERABLE EFFORT IN PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND FISCAL OVERSIGHT FOR FNIH GRANTS. SCIENTIFIC AND TECHNICAL PROGRESS IS MONITORED THROUGH SEMI-ANNUAL AND ANNUAL REPORTS FROM THE GRANTEES AS WELL AS THROUGH DIRECT CONTACT WITH INVESTIGATORS BOTH BY TELECONFERENCE AND SITE VISITS, AND FOLLOW UP TO PROGRESS REPORTS AND SITE VISITS WHERE SCIENTIFIC QUESTIONS OR ADMINISTRATIVE ISSUES ARE IDENTIFIED. SCIENTIFIC REPORT SUBMISSIONS COVER A WIDE RANGE OF ITEMS INCLUDING INDIVIDUAL OBJECTIVES AND OVERALL PROGRESS REVIEW, MILESTONE ACHIEVEMENT, PROJECT PLAN UPDATE, AND ANY OTHER SIGNIFICANT CHANGES. FINANCIAL REPORTING IS REQUIRED ANNUALLY FOR ALL OF THE GRANTEES, AND SEMI-ANNUALLY FOR INSTITUTIONS THAT REQUIRE ADDITIONAL OVERSIGHT, SUCH AS SOME DEVELOPING COUNTRY INSTITUTIONS. DUE DILIGENCE PROCEDURES, SUCH AS FNIH COMPLIANCE WITH THE USA PATRIOT ACT AND IRS REQUIREMENTS ON EXPENDITURE RESPONSIBILITIES, HAVE BEEN INCORPORATED INTO THE REPORTING PROCESS TO ENSURE THAT THE GRANTEES ARE COMPLYING WITH GRANT, LEGAL, FINANCIAL, AND REGULATORY REQUIREMENTS.	ExplanationTxt

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Govt Grants	Yes (X)	SolicitationOfGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (1)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

Field	Value	IRS element (for citing)
Person	CHRISTINE K OWENS	PersonNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	1851 N SCOTT STREET 460	AddressLine1Txt
City	ARLINGTON	CityNm
State Abbreviation	VA	StateAbbreviationCd
ZIP	22209	ZIPCd

Field	Value	IRS element (for citing)
Activity	ADVISEMENT ON RELATIONSHIP MANAGEMENT AND ADVISEMENT POLICY	ActivityTxt
Fundraiser Control Of Funds	0	FundraiserControlOfFundsInd
Gross Receipts	$0	GrossReceiptsAmt
Retained By Contractor	$78,000	RetainedByContractorAmt
Net To Organization	-$78,000	NetToOrganizationAmt

Field	Value	IRS element (for citing)
Total Retained By Contractors	$78,000	TotalRetainedByContractorsAmt
Total Net To Organization	-$78,000	TotalNetToOrganizationAmt
Licensed States	AL	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	AZ	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	CA	LicensedStatesCd
Licensed States	CO	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	DE	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	GA	LicensedStatesCd
Licensed States	HI	LicensedStatesCd
Licensed States	ID	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	IN	LicensedStatesCd
Licensed States	IA	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	LA	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MN	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	MT	LicensedStatesCd
Licensed States	NE	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	SD	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	TX	LicensedStatesCd
Licensed States	UT	LicensedStatesCd
Licensed States	VT	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WI	LicensedStatesCd
Licensed States	WY	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	2018 FNIH AWARD CEREMONY	Event1Nm
Gross Receipts Event1	$308,156	GrossReceiptsEvent1Amt
Charitable Contri Event1	$60,606	CharitableContriEvent1Amt
Gross Revenue Event1	$247,550	GrossRevenueEvent1Amt
Food And Beverage Event1	$21,971	FoodAndBeverageEvent1Amt
Other Direct Expenses Event1	$215,570	OtherDirectExpensesEvent1Amt
Event2	2019 FNIH AWARD CEREMONY	Event2Nm
Gross Receipts Event2	$60,000	GrossReceiptsEvent2Amt
Gross Revenue Event2	$60,000	GrossRevenueEvent2Amt
Other Direct Expenses Event2	$48,723	OtherDirectExpensesEvent2Amt
Gross Receipts Total	$368,156	GrossReceiptsTotalAmt
Charitable Contributions Tot	$60,606	CharitableContributionsTotAmt
Gross Revenue Total Events	$307,550	GrossRevenueTotalEventsAmt
Food And Beverage Total Events	$21,971	FoodAndBeverageTotalEventsAmt
Oth Direct Expnss Total Events	$264,293	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$286,264	DirectExpenseSummaryEventsAmt
Net Income Summary	$21,286	NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (27 entries)

Address Line1USAddress/AddressLine1Txt	Address Line2USAddress/AddressLine2Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt
BRIGHAM & WOMEN'S HOSPITAL
1620 TREMONT STREET 3RD FLOOR RM BC	3002	BOSTON	MA	02120	042312909	501(C)(3)	$369,870	RESEARCH
BROAD INSTITUTE
415 MAIN STREET		CAMBRIDGE	MA	02142	263428781	501(C)(3)	$224,848	RESEARCH
CASE WESTERN RESERVE UNIVERSITY
NORD HALL SUITE 615 10900 EUCLID	AVENUE	CLEVELAND	OH	44106	341018992	501(C)(3)	$357,653	RESEARCH
CATALYSIS FOUNDATION FOR HEALTH INC
1900 POWELL STREET SUITE 600		EMERYVILLE	CA	94608	208602047	501(C)(3)	$198,596	RESEARCH
DUKE UNIVERSITYHUMAN VACCINE INSTITUTE
2200 WEST MAIN STREET SUITE 820	ERWIN SQUARE PLAZA	DURHAM	NC	27705	560532129	501(C)(3)	$227,762	RESEARCH
FRED HUTCHINSON CANCER RESEARCH
1100 FAIRVIEW AVE N		SEATTLE	WA	98109	237156071	501(C)(3)	$350,856	RESEARCH
FRIENDS OF CANCER RESEARCH
1800 M STREET NW SUITE 1050 SUTH		WASHINGTON	DC	20036	521983273	501(C)(3)	$100,000	RESEARCH
JOHN HOPKINS UNIVERSITY
615 N WOLFE ST W1100		BALTIMORE	MD	21205	150595110	501(C)(3)	$212,697	RESEARCH
NIHCC
9000 ROCKVILLE PIKE		BETHESDA	MD	20892	520858115	170(C)(1) GOVT	$334,272	RESEARCH
NIHNCI
9000 ROCKVILLE PIKE		BETHESDA	MD	20892	520858116	170(C)(1) GOVT	$911,414	RESEARCH
NIHNIA
9000 ROCKVILLE PIKE		BETHESDA	MD	20892	520858117	170(C)(1) GOVT	$883,053	RESEARCH
NIHNIAID
9000 ROCKVILLE PIKE		BETHESDA	MD	20892	520858115	170(C)(1) GOVT	$3,750,789	RESEARCH
NIHNIAMS
9000 ROCKVILLE PIKE		BETHESDA	MD	20892	520858115	170(C)(1) GOVT	$1,967,764	RESEARCH
NIHNIMH
9000 ROCKVILLE PIKE		BETHESDA	MD	20892	520858115	170(C)(1) GOVT	$722,028	RESEARCH
NIHNINDS
9000 ROCKVILLE PIKE		BETHESDA	MD	20892	520858115	170(C)(1) GOVT	$846,807	RESEARCH
NIHOD
9000 ROCKVILLE PIKE		BETHESDA	MD	20892	520858115	170(C)(1) GOVT	$216,871	RESEARCH
REGENTS OF THE UNIVERSITY OF MICHIGAN
3003 SOUTH STATE STREET 1040	WOLVERINE TOWER	ANN ARBOR	MI	48109	386006309	170(C)(1) GOVT	$772,508	AMP-T2 DIABETES. DEPOSIT OF METSIM AND FUSION DATA INTO KNOWLEDGE PORTAL
SUTTER BAY HOSPITALS DBA CALIFORNIA PACIFIC MEDICAL CENTER
475 BRANNAN STREET SUITE 220		SAN FRANCISCO	CA	94107	940562680	501(C)(3)	$44,850	RESEARCH
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
MISSION HALL 550 16TH STREET 2ND	FLOOR	SAN FRANCISCO	CA	94143	946036493	501(C)(3)	$287,500	RESEARCH
UNIVERSITY OF SOUTHERN CALIFORNIA
SOTO STREET BUILDING 2001 SOTO	STREET	LOS ANGELES	CA	900899235	911642394	501(C)(3)	$803,151	RESEARCH
WESTERN MICHIGAN UNIVERSITY
1903 W MICHIGAN AVENUE		KALAMAZOO	MI	49008	386007327	501(C)(3)	$1,044,969	RESEARCH
UNIVERSITY OF LOUISIANA AT LAFAYETTE
104 UNIVERSITY CIRCLE		LAFAYETTE	LA	70503	726000820	501(C)(3)	$592,374	RESEARCH
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
ONE GUSTAVE L LEVY PLACE PO BOX	1498	NEW YORK	NY	10029	136171197	501(C)(3)	$165,587	RESEARCH
WEST VIRGINIA UNIVERSITY FOUNDATION
1 WATERFRONT PLACE 7TH FLOOR PO BOX	1650	MORGANTOWN	WV	26507	556017181	501(C)(3)	$61,320	RESEARCH
REGENTS OF THE UNIVERSITY OF MINNESOTA
NW 5957 PO BOX 1450		MINNEAPOLIS	MN	55485	416007513	501(C)(3)	$47,358	RESEARCH
REGENTS OF THE U OF CALIFORNIA SAN FRANCISCO
MISSION HALL 550 16TH STREET 2ND	FLOOR	SAN FRANCISCO	CA	94143	946036493	501(C)(3)	$42,064	RESEARCH
PRESIDENT AND FELLOWS OF HARVARD COLLEGE
PO BOX 415649		BOSTON	MA	02241	042103580	501(C)(3)	$42,062	RESEARCH

Field	Value	IRS element (for citing)
Total501c3 Org	27	Total501c3OrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp

Field	Value	IRS element (for citing)
Grant Type	AWARDS	GrantTypeTxt
Recipient	10	RecipientCnt
Cash Grant	$10,597	CashGrantAmt
Valuation Method Used	FMV	ValuationMethodUsedDesc

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	PROGRAM AND GRANTS MANAGEMENT STAFF INVEST CONSIDERABLE EFFORT IN PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND FISCAL OVERSIGHT FOR FNIH GRANTS. SCIENTIFIC AND TECHNICAL PROGRESS IS MONITORED THROUGH SEMI-ANNUAL AND ANNUAL REPORTS FROM THE GRANTEES AS WELL AS THROUGH DIRECT CONTACT WITH INVESTIGATORS BOTH BY TELECONFERENCE AND SITE VISITS, AND FOLLOW UP TO PROGRESS REPORTS AND SITE VISITS WHERE SCIENTIFIC QUESTIONS OR ADMINISTRATIVE ISSUES ARE IDENTIFIED. SCIENTIFIC REPORT SUBMISSIONS COVER A WIDE RANGE OF ITEMS INCLUDING INDIVIDUAL OBJECTIVES AND OVERALL PROGRESS REVIEW, MILESTONE ACHIEVEMENT, PROJECT PLAN UPDATE, AND ANY OTHER SIGNIFICANT CHANGES. FINANCIAL REPORTING IS REQUIRED ANNUALLY FOR ALL OF THE GRANTEES, AND SEMI-ANNUALLY FOR INSTITUTIONS THAT REQUIRE ADDITIONAL OVERSIGHT, SUCH AS FOR-PROFIT INSTITUTIONS. DUE DILIGENCE PROCEDURES, SUCH AS FNIH COMPLIANCE WITH THE USA PATRIOT ACT AND IRS REQUIREMENTS ON EXPENDITURE RESPONSIBILITIES, HAVE BEEN INCORPORATED INTO THE REPORTING PROCESS TO ENSURE THAT THE GRANTEES ARE COMPLYING WITH GRANT, LEGAL, FINANCIAL, AND REGULATORY REQUIREMENTS. FELLOWS SELECTED FOR FOUNDATION FELLOWSHIPS ARE SELECTED THROUGH NATIONWIDE AND INTERNATIONAL COMPETITIONS. THE CLINICAL RESEARCH TRAINING PROGRAM (CRTP) IS OPEN TO ALL THIRD YEAR STUDENTS ENROLLED IN MEDICAL OR DENTAL SCHOOLS. THE WOMEN'S HEALTH FELLOWSHIP PROGRAMS ARE OPEN TO DOCTORAL-LEVEL CANDIDATES WITHIN FIVE YEARS OF RECEIPT OF THE DOCTORAL DEGREE. APPLICATIONS, CONTAINING TRANSCRIPTS AND ESSAYS ON THEIR RESEARCH GOALS ARE SUBMITTED AND REVIEWED BY PANELS OF NIH SCIENTISTS WHO MAKE RECOMMENDATIONS FOR SELECTION. POTENTIAL FELLOWS ARE OFTEN BROUGHT TO THE CAMPUS FOR INTERVIEWS AND FINAL SELECTION. THE FOUNDATION'S FELLOWSHIPS ARE OPEN TO PROFESSIONALS WORKING AT VARIOUS STAGES OF THEIR RESEARCH CAREERS. APPLICANTS TO THE NEUROSCIENCE FELLOWSHIP, FOR EXAMPLE, ARE YOUNG SCIENTISTS WHO WILL BENEFIT FROM EXPERIENCE OF CLINICAL AND BASIC SCIENCE RESEARCH. THE DIRECTOR'S FELLOWSHIP IN COMPLEMENTARY AND ALTERNATIVE MEDICINE RESEARCH SEEKS A MORE EXPERIENCED SCIENTIST WHO IS WELL-POSITIONED TO BECOME A LEADER IN THE FIELD OF COMPLEMENTARY ALTERNATIVE MEDICINE.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Written Employment Contract	Yes (X)	WrittenEmploymentContractInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	0	AnyNonFixedPaymentsInd
Initial Contract Exception	0	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (12 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
DR MARIA C FREIRE
PRESIDENT AND EXECUTIVE DIRECTOR	$452,786	$0	$20,000	$0	$0	$0	$27,500	$0	$0	$0	$500,286	$0	$0	$0
MR DAVID WHOLLEY
SENIOR VP OF RESEARCH PARTNERSHIPS	$325,826	$0	$10,000	$0	$0	$0	$27,500	$0	$15,720	$0	$379,046	$0	$0	$0
DR STEPHANIE JAMES
SENIOR VP OF SCIENCE	$329,574	$0	$0	$0	$0	$0	$27,500	$0	$0	$0	$357,074	$0	$0	$0
MR DONALD HILL
CHIEF FINANCIAL OFFICER	$229,912	$0	$0	$0	$0	$0	$23,179	$0	$15,720	$0	$268,811	$0	$0	$0
MR KEVIN A KLOCK
VP OF OPERATIONS & GENERAL COUNSEL	$209,068	$0	$0	$0	$0	$0	$21,229	$0	$16,470	$0	$246,767	$0	$0	$0
MR ROBERT BALTHASER
VICE PRESIDENT OF ADVANCEMENT	$156,672	$0	$0	$0	$0	$0	$15,638	$0	$6,028	$0	$178,338	$0	$0	$0
MS JULIA WOLF-RODDA
SENIOR VP OF DEVELOPMENT	$216,062	$0	$0	$0	$0	$0	$21,729	$0	$15,070	$0	$252,861	$0	$0	$0
DR JOSEPH MENETSKI
ASSOCIATE VP OF RESEARCH PARTNERSHIP	$215,262	$0	$0	$0	$0	$0	$21,449	$0	$13,070	$0	$249,781	$0	$0	$0
DR DAVID O'BROCHTA
SCIENTIFIC PROGRAM MANAGER	$179,788	$0	$0	$0	$0	$0	$17,977	$0	$14,070	$0	$211,835	$0	$0	$0
DR KAREN TOUNTAS
SCIENTIFIC PROGRAM MANAGER	$175,732	$0	$2,500	$0	$0	$0	$17,757	$0	$15,570	$0	$211,559	$0	$0	$0
DR STACEY ADAM
DIRECTOR OF CANCER	$165,609	$0	$0	$0	$0	$0	$16,548	$0	$6,028	$0	$188,185	$0	$0	$0
DR ROSA CANET AVILES
DIRECTOR OF NEUROSCIENCE	$163,632	$0	$0	$0	$0	$0	$16,600	$0	$15,570	$0	$195,802	$0	$0	$0

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Contribution	2	ContributionCnt
Noncash Contributions Rpt F990	$110,839	NoncashContributionsRptF990Amt
Method Of Determining Revenues	STOCK PRICE	MethodOfDeterminingRevenuesTxt

Other Non Cash Contri Table OtherNonCashContriTableGrp

Field	Value	IRS element (for citing)
Non Cash Checkbox	Yes (X)	NonCashCheckboxInd
Desc	GOODS	Desc
Contribution	1	ContributionCnt
Noncash Contributions Rpt F990	$5,950	NoncashContributionsRptF990Amt

Field	Value	IRS element (for citing)
Any Property That Must Be Held	0	AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts	0	ReviewProcessUnusualNCGiftsInd
Third Parties Used	0	ThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 2	DR. FREIRE, PRESIDENT OF THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH, INC. (FNIH), IS A NON-EXECUTIVE MEMBER OF THE BOARD OF DIRECTORS OF ALEXANDRIA REAL ESTATE EQUITIES (ARE). MR. JOEL MARCUS, CEO AND CHAIRMAN OF ARE IS A NON-EXECUTIVE MEMBER OF THE FNIH BOARD OF DIRECTORS.
FORM 990, PART VI, SECTION B, LINE 11B	PRIOR TO THE SUBMISSION OF THE FOUNDATION FOR NIH'S FORM 990 TO THE INTERNAL REVENUE SERVICE, EACH VOTING MEMBER OF THE BOARD OF DIRECTORS SHALL BE PROVIDED WITH A COPY OF THE DRAFT FORM 990 AS APPROVED BY THE CHIEF FINANCIAL OFFICER.
FORM 990, PART VI, SECTION B, LINE 12C	THE FOUNDATION REQUIRES DIRECTORS, OFFICERS, VOLUNTEER COMMITTEE MEMBERS, AND STAFF MEMBERS TO DISCLOSE REAL AND APPARENT CONFLICTS OF INTEREST FOR THEMSELVES AND THEIR FAMILY MEMBERS AND TO ANNUALLY SIGN A STATEMENT OF COMPLIANCE. AFTER A CONFLICT OR AN APPARENT CONFLICT OF INTEREST HAS BEEN DISCLOSED, THE BOARD OF DIRECTORS OR THE BOARD COMMITTEE, OR THEIR DESIGNEE, SHALL DETERMINE IF THE CONFLICT OF INTEREST OR THE APPEARANCE OF A CONFLICT OF INTEREST EXISTS AND IS MATERIAL AND WILL DECIDE HOW IT IS TO BE MANAGED OR ELIMINATED.
FORM 990, PART VI, SECTION B, LINE 15	THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS WILL REVIEW AND APPROVE THE SALARIES OF THE EXECUTIVE DIRECTOR AND KEY EMPLOYEES ANNUALLY.
FORM 990, PART VI, SECTION C, LINE 19	ALL SUCH DOCUMENTS ARE AVAILABLE UPON REQUEST. IN ADDITION, THE GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS ARE AVAILABLE ON THE FNIH WEBSITE.
FORM 990, PART XII, LINE 2C:	PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.